SAB Biotherapeutics, Inc. — 10-Q Filings
15 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by SAB Biotherapeutics, Inc. (SABSW), sorted by most recent first. Each row links to the full filing on EdgarLookup. SAB Biotherapeutics, Inc. has filed 15 10-Q documents with the SEC since 2020. To view all SEC filings by SAB Biotherapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
25-NSE
3
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-K
8-K/A
AW
CERT
CORRESP
D
DEF 14A
DEFA14A
DRSLTR
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
RW
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001193125-25-280572 | Nov 14, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-104566 | Aug 7, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-067554 | May 9, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0000950170-24-122443 | Nov 6, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-094084 | Aug 8, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-062367 | May 20, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-23-063076 | Nov 13, 2023 | Sep 30, 2023 |
| 10-Q | FORM 10-Q | 0001437749-23-024224 | Aug 21, 2023 | Jun 30, 2023 |
| 10-Q | FORM 10-Q | 0001437749-23-014634 | May 15, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0000950170-22-025094 | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-016221 | Aug 10, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-009722 | May 12, 2022 | Mar 31, 2022 |
| 10-Q | — | 0001493152-21-029551 | Nov 22, 2021 | Sep 30, 2021 |
| 10-Q | — | 0001493152-21-019063 | Aug 9, 2021 | Jun 30, 2021 |
| 10-Q | — | 0001493152-21-012524 | May 21, 2021 | Mar 31, 2021 |